Global Health (MEDANTA) Q1 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 24/25 earnings summary
27 Aug, 2025Executive summary
Approved unaudited standalone and consolidated financial results for the quarter ended June 30, 2024.
Board approved construction of service apartments/guest house at Medanta campus with Rs 250 Cr capex to enhance patient experience.
Notice issued for the 20th Annual General Meeting to be held on September 19, 2024.
Financial highlights
Standalone revenue from operations for Q1 FY25 was ₹6,114.49 million, up from ₹5,505.07 million in Q1 FY24.
Standalone profit after tax for Q1 FY25 was ₹962.84 million, compared to ₹862.12 million in Q1 FY24.
Consolidated revenue from operations for Q1 FY25 was ₹8,610.77 million, up from ₹7,795.80 million in Q1 FY24.
Consolidated profit after tax for Q1 FY25 was ₹1,062.86 million, compared to ₹1,020.10 million in Q1 FY24.
Outlook and guidance
Expansion with new service apartments/guest house at Gurgaon campus to support growing international and domestic patient demand.
Latest events from Global Health
- Q1 FY 2027 saw 26% revenue growth, margin expansion, and major hospital expansion plans.MEDANTA
Q1 26/27 - Strong revenue and profit growth, network expansion, and disciplined capex marked FY26.MEDANTAQ4 25/26
- Q3 FY2026 saw 19% income growth, strong margins, and continued expansion despite ramp-up costs.MEDANTAQ3 25/26
- Q2 FY2026 delivered double-digit growth, major expansion, and strong cash flows.MEDANTAQ2 25/26
- Strong Q2 and H1 FY25 growth, new incentive plan, and expansion with a new hospital agreement.MEDANTAQ2 24/25
- Double-digit growth in revenue and profit, with major expansions and strong patient volume momentum.MEDANTAQ3 24/25
- Double-digit revenue growth, strong margins, and major expansion projects marked FY2025.MEDANTAQ4 24/25
- Record Q1 revenue, profit, and margins with robust expansion and a proposed dividend.MEDANTAQ1 25/26